Codestin Search App

Edited by:

Sibel Saya, PhD, University of Melbourne, Australia
Elizabeth Bancroft, PhD, The Royal Marsden Hospital, and The Institute of Cancer Research, United Kingdom

Submission Status: Open | Submission Deadline: 8 May 2026

A hand with a medical glove is holding a magnifying glass in front of lines of DNA code. The word cancer is written in the DNA code. Hereditary Cancer in Clinical Practice is presenting a new Collection on Integration of Genetics into Oncology Practice. This Collection invites original research articles, reviews, case studies, and comments, aiming to foster discussions on how new genetic and genomic tests are transforming clinical oncology care across the cancer continuum.

Image credit: © zmeel/E+/Gettyimages

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.

Submit to Collection

Meet the Guest Editors

Back to top

Sibel Saya, PhD, University of Melbourne, Australia

Photo of Sibel Saya Dr Saya is a research fellow and an academic genetic counsellor at the University of Melbourne Centre for Cancer Research and the Department of General Practice and Primary Care. Her PhD examined the use of a genomic risk score for targeted colorectal cancer screening within general practice. Dr Saya's research areas of expertise include the use of new genetic and genomics tests within general practice, risk-stratified cancer screening, and she specializes in clinical trials that examine these questions.

Elizabeth Bancroft, PhD, The Royal Marsden Hospital, and The Institute of Cancer Research, United Kingdom

Photo of Elizabeth Bancroft Dr Bancroft is a Nurse Consultant in Oncogenetics Research at the Royal Marsden Hospital and Institute of Cancer Research, with a joint appointment as Chief Nurse of the North Thames Genomic Medicine Service Alliance. With 20+ years in cancer genetics, she focuses on integrating genetics into the prostate cancer screening and treatment pathway. She leads a nurse-led genetic risk clinic and a research programme on psychosocial aspects of integrating genetics into cancer care and increasing engagement with groups underrepresented in research.

About the Collection

The integration of genetics into oncology practice is transforming the landscape of cancer care, offering unprecedented opportunities to personalize prevention, diagnosis, and treatment. As our understanding of oncogenetics deepens, innovations in genetic and genomic testing are enabling more accurate identification of inherited cancer predispositions. In parallel, the application of polygenic risk scores is enhancing risk stratification and informing targeted therapies, marking the beginning of a new era of precision medicine.

This Collection aims to highlight cutting-edge research and clinical advancements that bridge the gap between genetic discoveries and their implementation in oncology. We welcome contributions that explore how emerging technologies, clinical studies, and ethical frameworks are shaping the future of cancer care. Special attention is given to the impact of genetics and genomics across the cancer continuum, from risk assessment and prevention to early detection, treatment, and survivorship.

We invite submissions of original research articles, reviews, case studies, and comments on topics including, but not limited to:

•   Applications of genetic testing across all cancer types
•   Advances in somatic and germline genomic testing, including polygenic risk scores
•   The impact of genetics and genomics on cancer prevention, early detection, and treatment
•   Use of genetic and genomic tools across the cancer care continuum
•   Integration of genetics and genomics in primary, secondary, and tertiary care
•   Clinical and implementation studies in oncogenetics
•   Development and application of targeted therapies in precision oncology
•   Integration of genetic counseling into oncology practice
•   Ethical, legal, and social implications of cancer genetics
•   The role of cancer registries in improving care for individuals with inherited predispositions

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original research articles, reviews, case studies, and comments. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Integration of Genetics into Oncology Practice" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.